Alzamend Neuro, Inc. (ALZN) stock
ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 10, 2026Score 4/30
$1.13−0.05 (-4.24%)
Close on Nov 17, 2026Market cap $5.45MP/E –Yield –
Alzamend Neuro ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Alzamend Neuro
Alzamend Neuro has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?